“The global medical image analysis software market is anticipated to cross USD 7 Billion by 2030”, says Visiongain

15 October 2019
Pharma

Visiongain has launched a new pharma report ‘’Medical Image Analysis Software Market Report 2020-2030’’ by Type (3D imaging, 2D Imaging, 4D Imaging), by Software Type (Standalone Software, Integrated Software), by Imaging Technology {Ultrasound Imaging (2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging), Tomography (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Single-Photon Emission Tomography), Radiographic Imaging, X-Ray, Other Imaging Technologies}, by Application (Cardiology, Dental, Mammography, Neurology, Oncology, Orthopedic, Obstetrics and Gynecology, Urology & Nephrology), by End Users (Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Hospitals, Research and Academic Institutions)

The global medical image analysis software market is anticipated to grow at a lucrative CAGR of 8.7% and anticipated to cross USD 7 Billion by 2030.

The increasing interest in the field of health care has paved the way for creative approaches to medical diagnosis and clinical procedures. Since health is deemed a wealth, healthcare companies are striving to use advanced medical processes and therapy methods in conjunction with computational techniques, making use of improvements in hardware resources. The ever-ending necessity in the healthcare industry is precision in the diagnosis of disease and precision in clinical procedures and enhancement in medical devices. This has resulted in numerous clinically proven best practices. However, to uncover hidden knowledge from the information, more needs to be done with ever-growing medical information.

An enormous quantity of information is generated by the healthcare industry. Smart processing of such information can show hidden relationships between information items that will assist in clinical procedures. The growing use of medical picture processing can enhance service quality to decrease death tolls and enhance a country's citizens' health norms.

It is anticipated that the X-ray imaging segment will be the fastest-growing segment over the forecast period. X-ray has applications for bone or tissue sample examination. Using imaging software, X-ray image data is analyzed. Developing the software for medical x-ray image analysis has made treatment and information management simple for medical staff. The information can be readily shared at distant locations among healthcare providers. This is a major factor contributing to the market growth. For instance, GE's Rhythm Radiography which is a sophisticated x-ray software suite incorporates innovative image acquisition techniques, and DICONDE compliant data management tools for X-ray inspection methods, including film digitization, digital radiography, and CT.

North America holds majority of market share followed by Europe and will continue to dominate in the future as a result of as growing geriatric population, the large number of imaging centers in this region, high incidence/prevalence of various diseases, growing adoption of technologically advanced imaging systems, and growing awareness about the benefits of early disease diagnosis among other factors. While Europe is anticipated to account for the second-largest market share owing to increasing demand for non-radiation diagnostic solutions in the healthcare industry/research organizations and growing government investments in the region.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products to strengthen their position in the global medical image analysis software market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the market.

The comprehensive market report features companies such as AGFA-Gevaert Group (AGFA), Aquilab, Bruker Corporation, Carestream Health, Inc. (A Subsidiary of Onex Corporation), ClaroNav, Inc., Esaote S.P.A, GE Healthcare, INFINITT Healthcare Co, Ltd., Merge Healthcare Inc. (Part of IBM Corporation), Mirada Medical Limited, Philips Healthcare (A Subsidiary of Royal Philips Electronics), Sciencesoft USA Corporation, Siemens Healthcare (A Division of Siemens AG), Spacelabs Healthcare, Inc., Toshiba Medical Systems Corporation,

Xinapse Systems Ltd. among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020–2030 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

Read

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

Read

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

Read

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever